Free Trial

Canopy Growth (TSE:WEED) Sets New 12-Month Low - Should You Sell?

Canopy Growth logo with Medical background

Canopy Growth Corp (TSE:WEED - Get Free Report) shares hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as C$3.09 and last traded at C$3.19, with a volume of 629061 shares changing hands. The stock had previously closed at C$3.19.

Wall Street Analyst Weigh In

Separately, ATB Capital downgraded Canopy Growth from a "sector perform" rating to an "underperform" rating and dropped their target price for the company from C$6.00 to C$4.00 in a research report on Tuesday, December 17th.

View Our Latest Report on WEED

Canopy Growth Stock Performance

The stock has a market capitalization of C$273.25 million, a PE ratio of -0.41, a P/E/G ratio of -0.01 and a beta of 1.79. The business's fifty day moving average price is C$4.67 and its 200-day moving average price is C$6.71. The company has a debt-to-equity ratio of 117.00, a current ratio of 2.15 and a quick ratio of 2.32.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a "Strong Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Transportation Stocks to Watch in 2025: Top Picks for Growth
Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines